Literature DB >> 19631762

Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia.

Alexander C Ford1, Avantika Marwaha, Allen Lim, Paul Moayyedi.   

Abstract

BACKGROUND & AIMS: Dyspepsia and irritable bowel syndrome (IBS) are common conditions that can coexist in patients. We performed a systematic review and meta-analysis to estimate prevalence of IBS in dyspepsia.
METHODS: Relevant articles published through August 2008 were identified from MEDLINE and EMBASE literature searches (23,457 citations). Eligible studies included adults recruited from the community, the workplace, blood donation or screening clinics, and family physician offices or internal medicine clinics. Selected studies reported prevalence of dyspepsia and IBS within the same population. The prevalence of IBS in subjects with and without dyspepsia was pooled for all studies and compared. Odds ratios (OR) and confidence intervals (CI) were calculated. The degree of overlap between dyspepsia and IBS was determined.
RESULTS: Of 239 papers evaluated, 150 reported prevalence of dyspepsia and 19 (involving 18,173 subjects) reported the proportion of subjects with IBS within the same population. The prevalence of dyspepsia was 27% (95% CI, 23%-31%). The prevalence of IBS in subjects with dyspepsia was 37% (95% CI, 30%-45%) compared with 7% (95% CI, 5%-10%) in those without. The pooled OR for IBS in subjects with dyspepsia was 8 (95% CI, 5.74-11.16). The degree of overlap between the 2 conditions varied from 15% to 42%, depending on diagnostic criteria used for each.
CONCLUSIONS: Individuals with dyspepsia have an 8-fold increase in prevalence of IBS compared with the population. The strength of the association suggests common pathogenic mechanisms. Dyspeptic patients should be assessed routinely for IBS. Copyright (c) 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19631762     DOI: 10.1016/j.cgh.2009.07.020

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  53 in total

1.  Overlap syndrome of functional dyspepsia and irritable bowel syndrome - are both diseases mutually exclusive?

Authors:  Hidekazu Suzuki; Toshifumi Hibi
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

Review 2.  ACG and CAG Clinical Guideline: Management of Dyspepsia.

Authors:  Paul Moayyedi; Brian E Lacy; Christopher N Andrews; Robert A Enns; Colin W Howden; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2017-06-20       Impact factor: 10.864

3.  Functional dyspepsia.

Authors:  Rita Brun; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

Review 4.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

5.  Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome.

Authors:  Ruchit Sood; Alexander C Ford
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

6.  Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population.

Authors:  Richard A Brook; Nathan L Kleinman; Rok Seon Choung; James E Smeeding; Nicholas J Talley
Journal:  Dig Dis Sci       Date:  2011-07-13       Impact factor: 3.199

7.  New classification Rome IV functional dyspepsia and subtypes.

Authors:  Seiji Futagami; Hiroshi Yamawaki; Shuhei Agawa; Kazutoshi Higuchi; Go Ikeda; Hiroto Noda; Kumiko Kirita; Teppei Akimoto; Mako Wakabayashi; Noriko Sakasegawa; Yasuhiro Kodaka; Nobue Ueki; Tetsuro Kawagoe; Katsuhiko Iwakiri
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-19

8.  The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.

Authors:  Imran Aziz; Olafur S Palsson; Hans Törnblom; Ami D Sperber; William E Whitehead; Magnus Simrén
Journal:  Am J Gastroenterol       Date:  2017-11-14       Impact factor: 10.864

9.  Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes.

Authors:  Ami D Sperber; Roy Dekel
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

10.  The current prevalence of irritable bowel syndrome in Asia.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.